Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis
Abstract
BACKGROUND: Dialysate composition is crucial for managing secondary hyperparathyroidism (SHPT) in patients on hemodialysis. Acetate-based dialysates elevate serum acetate and trigger adverse effects, while citrate and hydrochloric acid formulations might offer distinct clinical benefits. METHODS: In this longitudinal observational real-life study, 876 adult patients on hemodialysis were classified by acid component of the dialysate (acetic acid, citric acid, or hydrochloric acid). Monthly pre-dialysis parathyroid hormone (PTH) and bone-mineral biomarkers were measured. A linear mixed model (LMM), adjusted for baseline PTH, demographics, and clinical covariates, evaluated PTH trajectories over two years. The significance of the main effect of dialysate and its interaction with time was assessed using likelihood-ratio tests (LRT). RESULTS: At baseline, serum PTH was significantly higher in the acetate group. The LMM confirmed significant influence of dialysate type (p < 0.001) and its interaction with time (p = 0.048) on PTH trajectories. Over two years, acetate showed a modest, non-significant PTH reduction of 2.9% (95% CI: -8.8% to +3.4%), whereas hydrochloric acid resulted in a significant cumulative PTH reduction of 10.9% (95% CI: -15.7% to -0.2%), with a significantly different yearly slope versus acetate (p = 0.044). Citrate showed a modest, non-significant change compared to acetate (-2.3%; 95% CI: -6.7% to +8.4%). Baseline PTH, phosphate, prior hypercalcemia, and dialysate calcium concentration were major predictors in the model. CONCLUSIONS: In adjusted longitudinal analyses, hydrochloric acid-based bicarbonate dialysate was associated with a steeper decline in pre-dialysis PTH over two years compared with acetate, while citrate did not differ from acetate. Prospective studies are needed to confirm whether buffer composition influences PTH control under standardized calcium-bath strategies.
Related
- Combination of Clinical Frailty Score and Myostatin Concentrations as Mortality Predictor in Hemodialysis Patients
- B-vitamin concentrations in raw milk from dairy cows receiving diets with different forages and grassland contents and the resulting fermented milk products (cheese and yogurt)
- Vitamin D alleviates indoxyl sulfate-induced inflammatory and cholesterol dysregulation in macrophages: Implications for vascular health in patients receiving hemodialysis
- Bone response to intermittent parathyroid hormone (PTH) is both genetic and sex specific
- Parathyroid Hormone Receptor 1 Signaling Encodes Multifaceted Metabolic Programs in AgRP Neurons
BibTeX
@article{torres2026effect,
title = {{Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis}},
author = {Pablo Antonio Ureña Torres and Moustafa Naja and Minh Hoang Tran and Martine Cohen-Solal and Jordi Bover and Anne Kolko and Pascal Seris and Ibrahim Farah and Natalia Alençar-De-Pinho and Ziad A. Massy and Charles Chazot},
journal = {PLoS ONE},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0345776},
url = {https://hal.science/hal-05845351v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis
AU - Pablo Antonio Ureña Torres
AU - Moustafa Naja
AU - Minh Hoang Tran
AU - Martine Cohen-Solal
AU - Jordi Bover
AU - Anne Kolko
AU - Pascal Seris
AU - Ibrahim Farah
AU - Natalia Alençar-De-Pinho
AU - Ziad A. Massy
AU - Charles Chazot
PY - 2026
DA - 2026/10/30
JO - PLoS ONE
DO - 10.1371/journal.pone.0345776
UR - https://hal.science/hal-05845351v1
AB - BACKGROUND: Dialysate composition is crucial for managing secondary hyperparathyroidism (SHPT) in patients on hemodialysis. Acetate-based dialysates elevate serum acetate and trigger adverse effects, while citrate and hydrochloric acid formulations might offer distinct clinical benefits. METHODS: In this longitudinal observational real-life study, 876 adult patients on hemodialysis were classified by acid component of the dialysate (acetic acid, citric acid, or hydrochloric acid). Monthly pre-dialysis parathyroid hormone (PTH) and bone-mineral biomarkers were measured. A linear mixed model (LMM), adjusted for baseline PTH, demographics, and clinical covariates, evaluated PTH trajectories over two years. The significance of the main effect of dialysate and its interaction with time was assessed using likelihood-ratio tests (LRT). RESULTS: At baseline, serum PTH was significantly higher in the acetate group. The LMM confirmed significant influence of dialysate type (p < 0.001) and its interaction with time (p = 0.048) on PTH trajectories. Over two years, acetate showed a modest, non-significant PTH reduction of 2.9% (95% CI: -8.8% to +3.4%), whereas hydrochloric acid resulted in a significant cumulative PTH reduction of 10.9% (95% CI: -15.7% to -0.2%), with a significantly different yearly slope versus acetate (p = 0.044). Citrate showed a modest, non-significant change compared to acetate (-2.3%; 95% CI: -6.7% to +8.4%). Baseline PTH, phosphate, prior hypercalcemia, and dialysate calcium concentration were major predictors in the model. CONCLUSIONS: In adjusted longitudinal analyses, hydrochloric acid-based bicarbonate dialysate was associated with a steeper decline in pre-dialysis PTH over two years compared with acetate, while citrate did not differ from acetate. Prospective studies are needed to confirm whether buffer composition influences PTH control under standardized calcium-bath strategies.
SN - 1932-6203
SN - 1932-6203
ER -